Evidence map›Paper›PMID 41732062›Full record

ArticlePain practice : the official journal of World Institute of Pain2026

The Effects of Invasive Motor Cortex Stimulation for Neuropathic Pain: Do We See the Full Picture?

Erkan Kurt, Eline Bijl, Inge Arnts, Suzanne Pouwels, Linda Kollenburg, Jeremy Hanemaaijer, Robert van Dongen, Yvonne Engels, Kris C P Vissers, Dylan J H A Henssen

Abstract read
In one paragraph

Article in Pain practice : the official journal of World Institute of Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erkan KurtDepartment of Neurosurgery, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Eline BijlDepartment of Neurosurgery, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0003-0847-6479
Inge ArntsDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Suzanne PouwelsDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Linda KollenburgDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Jeremy HanemaaijerDepartment of Neurosurgery, John Radcliffe Hospital, Oxford, UK.
Robert van DongenDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Yvonne EngelsDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Kris C P VissersDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Dylan J H A HenssenDepartment of Medical Imaging, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInvasive motor cortex stimulation (iMCS) can be a last-resort treatment of chronic neuropathic pain syndromes. There is evidence that iMCS was found to influence pain intensity, quality of life scores, and pain medication intake in clinical practice. Albeit, qualitative studies published over the last years showed that the expectations and experiences of patients have a significant impact on treatment outcomes. This paper focus on these experiences of chronic neuropathic pain patients treated with iMCS.

objectivesThe aim of this interview study was to map the experiences of patients treated with iMCS in order to evaluate the multidimensional effects of iMCS. MATERIALS AND

methodsTwenty-eight patients with chronic neuropathic pain treated with iMCS between 2005 and 2018 were interviewed individually. All interviews were semi-structured using a predefined topic list. An inductive iterative process was performed during the interviews using the constant comparative method. All interviews were audio-recorded and transcribed verbatim afterwards. Transcripts were coded using direct content analysis. The derived codes were structured into categories and themes. Basic quantitative demographic data were collected, and the decrease in pain intensity after 2 years iMCS was calculated.

resultsContent analysis of the interviews revealed ten relevant categories, which could be structured into three themes: 1. Influence of the iMCS procedure on patients' live; 2. Effects of iMCS on quality of life and participation and 3. Acceptance and satisfaction. In total, 32% (8/25) were identified as responders, and 68% (17/25) as non-responders. Most patients (71%, 20/28) indicated they would undergo iMCS again. Three patients deceased before the end of the study.

conclusionThis study suggests that the effects of iMCS should be assessed in a more multidimensional way compared to only the effect on pain as patients confided that the true treatment effect and patient satisfaction were based more on improvements of their quality of life, enabling patients to participate again in society in a meaningful way. In clinical practice, this study emphasizes the need for thorough patient education and realistic expectation management prior to implantation, highlighting both potential benefits and limitations to support informed decision-making.

Indexed as

Chronic PainDeep Brain StimulationMotor CortexNeuralgiaAdultAgedFemaleHumansMaleMiddle AgedPain MeasurementQuality of LifeTreatment Outcome

Identifiers

PMID41732062
PMCPMC12930118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.